Reflections from news and commentary of the day
Subscribe To
Posts
Comments
Friday, July 6, 2018
FDA halts one of the first human CRISPR studies before it begins - MIT Technology Review
FDA halts one of the first human CRISPR studies before it begins - MIT Technology Review: A trial planning to use the gene-editing tool CRISPR on sickle-cell patients has been put on hold because of unspecified questions from US regulators.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment